| 1 |
Nicholson AG，Tsao MS，Beasley MB，et al.The 2021 WHO classification of lung tumors： impact of advances since 2015［J］.J Thorac Oncol，2022，17（3）： 362-387.
|
| 2 |
韩宝惠.中华医学会肺癌临床诊疗指南（2022 版）［J］.中华肿瘤杂志，2022，44（6）： 457-490.
|
| 3 |
Liang Y，Wang L，Zhu Y，et al.Primary pulmonary lymphoepitheliomalike carcinoma： fifty-two patients with long-term follow-up ［J］.Cancer，2012，118（19）： 4748-4758.
|
| 4 |
Chen JW，Dhahbi J.Lung adenocarcinoma and lung squamous cell carcinoma cancer classification，biomarker identification，and gene expression analysis using overlapping feature selection methods［J］.Sci Rep，2021，11（1）： 13323.
|
| 5 |
Nakamura H，Sakai H，Kimura H，et al.Difference in postsurgical prognostic factors between lung adenocarcinoma and squamous cell carcinoma［J］.Ann Thorac Cardiovasc Surg，2017，23（6）： 291-297.
|
| 6 |
Kawase A，Yoshida J，Ishii G，et al.Differences between squamous cell carcinoma and adenocarcinoma of the lung： are adenocarcinoma and squamous cell carcinoma prognostically equal？ ［J］.Jpn J Clin Oncol，2012，42（3）： 189-195.
|
| 7 |
Meng F，Zhang L，Ren Y，et al.The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates［J］.J Cell Physiol，2019，234（7）： 10918-10925.
|
| 8 |
Lin HT，Liu FC，Wu CY，et al.Epidemiology and survival outcomes of lung cancer： a population-based study［J］.Biomed Res Int，2019，2019： 8148156.
|
| 9 |
Grinberg RD，Refaely Y，Cohen LB，et al.Lung cancer in israel［J］.J Thorac Oncol，2020，15（4）： 493-498.
|
| 10 |
Corrales L，Rosell R，Cardona AF，et al.Lung cancer in never smokers：The role of different risk factors other than tobacco smoking［J］.Crit Rev Oncol/Hematol，2020，148： 102895.
|
| 11 |
Zang R，Shi JF，Lerut TE，et al.Ten-year trends of clinicopathologic features and surgical treatment of lung cancer in China［J］.Ann Thorac Surg，2020，109（2）： 389-395.
|
| 12 |
Huang CJ，Chan KY，Lee MY，et al.Computed tomography characteristics of primary pulmonary lymphoepithelioma-like carcinoma［J］.Br J Radiol，2007，80（958）： 803-806.
|
| 13 |
Ma H，Wu Y，Lin Y，et al.Computed tomography characteristics of primary pulmonary lymphoepithelioma-like carcinoma in 41 patients［J］.Eur J Radiol，2013，82（8）： 1343-1346.
|
| 14 |
Sharma A，Fidias P，Hayman LA，et al.Patterns of lymphadenopathy in thoracic malignancies［J］.Radiographics，2004，24（2）： 419-434.
|
| 15 |
丁小辉，陈本宝，陈雅青.多层螺旋CT 检查对原发性肺淋巴上皮瘤样癌的诊断价值分析［J］.中国现代医生，2023，61（18）：57-60.
|
| 16 |
Han AJ，Xiong M，Gu YY，et al.Lymphoepithelioma-like carcinoma of the lung with a better prognosis.A clinicopathologic study of 32 cases［J］.Am J Clin Pathol，2001，115（6）： 841-850.
|
| 17 |
Huang CJ，Chan KY，Lee MY，et al.Computed tomography characteristics of primary pulmonary lymphoepithelioma-like carcinoma［J］.Br J Radiol，2007，80（958）： 803-806.
|
| 18 |
Ma H，Wu Y，Lin Y，et al.Computed tomography characteristics of primary pulmonary lymphoepithelioma-like carcinoma in 41 patients［J］.Eur J Radiol，2013，82（8）： 1343-1346.
|
| 19 |
Ho JC，Wong MP，Lam WK.Lymphoepithelioma-like carcinoma of the lung［J］.Respirology，2006，11（5）： 539-545.
|
| 20 |
Chang YL，Wu CT，Shih JY，et al.New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas［J］.Am J Surg Pathol，2002，26（6）： 715-723.
|
| 21 |
Wu YX，Zhang WL，Wang TM，et al.Genomic landscapes of Epstein-Barr virus in pulmonary lymphoepithelioma-like carcinoma［J］.J Virol，2022，96（4）： e0169321.
|
| 22 |
鲍军芳，魏新华，江新青.原发性肺淋巴上皮瘤样癌的CT 表现：附14 例报告及文献复习［J］.中国CT 和MRI 杂志，2016，14（11）： 60-62.
|
| 23 |
尹文娟，苏 丹，谭蔚泓.淋巴上皮瘤样癌分子病理研究进展［J］.中国临床新医学杂志，2021，9（14）： 845-851.
|
| 24 |
Lin CY，Chen YJ，Hsieh MH，et al.Advanced primary pulmonary lymphoepithelioma-likecarcinoma：clinicalmanifestations，treatment，and outcome［J］.J Thorac Dis，2017，9（1）： 123-128.
|
| 25 |
Li QW，Qiu B，Hu WM，et al.Plasma Epstein-Barr virus deoxyribonucleic acid copy number predicts disease progression in stage Ⅰ-Ⅱpulmonary lymphoepithelioma-like carcinoma ［ J］.Front Oncol，2020，10： 1487.
|
| 26 |
Hong HZ，Li JK，Zhang JT，et al.Neoadjuvant immunotherapy in patients with pulmonary lymphoepithelioma-like carcinoma［J］.Lung Cancer，2023，181： 107-220.
|
| 27 |
Wu Z，Xian X，Wang K，et al.Immune checkpoint blockade therapy may be a feasible option for primary pulmonary lymphoepitheliomalike carcinoma［J］.Front Oncol，2021，11： 626566.
|
| 28 |
Zhong YM，Chen J，Jiang J，et al.Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma-like carcinoma ［J］.Clin Transl Immunology，2024，13（6）： e1515.
|
| 29 |
Zou QH，Liu H，Huang CW，et al.Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepitheliomalike carcinoma： a retrospective single-arm cohort study［J］.Transl Lung Cancer Res，2023，12（1）： 96-108.
|
| 30 |
Weng W，Sheng W，Wang L.Human papillomavirus-associated lymphoepithelioma-like carcinoma of the anal canal： a case report and literature review ［J］.Front Med （Lausanne），2021，8：766960.
|
| 31 |
Pazos M，Eze C，Kahnert K，et al.Novel multimodal management of post-partum synchronous metastatic pulmonary EBV-associated lymphoepithelioma-like carcinoma （ LELC）-a case report ［ J］.Diagnostics （Basel），2021，11（11）： 2072.
|
| 32 |
Zhong YM，Yin K，Chen Y，et al.PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma［J］.Front Immunol，2022，13： 951817.
|
| 33 |
Wang L，Lin Y，Cai Q，et al.Detection of rearrangement of anaplastic lymphoma kinase （ALK） and mutation of epidermal growth factor receptor （EGFR） in primary pulmonary lymphoepithelioma-like carcinoma［J］.J Thorac Dis，2015，7（9）： 1556-1562.
|
| 34 |
Liu Q，Ma G，Yang H，et al.Lack of epidermal growth factor receptor gene mutations in exons 19 and 21 in primary lymphoepithelioma-like carcinoma of the lung［J］.Thorac Cancer，2014，5（1）： 63-67.
|
| 35 |
Xie C，Xu X，Wu B，et al.Primary pulmonary lymphoepitheliomalike carcinoma in non-endemic region： A case report and literature review［J］.Medicine （Baltimore），2018，97（8）： e9976.
|
| 36 |
Kim C，Rajan A，DeBrito PA，et al.Metastatic lymphoepitheliomalike carcinoma of the lung treated with nivolumab： a case report and focused review of literature［J］.Transl Lung Cancer Res，2016，5（6）： 720-726.
|
| 37 |
Liu Y，Long L，Liu J，et al.Case report：anlotinib reverses nivolumab resistance in advanced primary pulmonary lymphoepithelioma-like carcinoma with FGFR3 gene amplification［J］.Front Oncol，2021，11： 749682.
|